CNC:NYSECentene Corporation Analysis

Centene (CNC) is trading well above its 20‑day and 50‑day moving averages, confirming a bullish price direction, but the RSI near 66 places the stock in an overbought zone and the MACD histogram has turned negative, signaling a potential short‑term pullback. Volume has been trending lower and the price sits just below the identified resistance around $60, while volatility remains elevated at over 50% for the past month, suggesting heightened price swings despite a beta well below 1 that indicates limited market‑wide risk. Valuation metrics show a forward PE that is roughly half the industry average and a price‑to‑book near 1.3, implying the stock is priced attractively relative to peers, yet profitability is still negative with a trailing loss per share and a negative ROE.
Recent earnings released a surprise beat, with adjusted EPS guidance turning positive for 2026 and Deutsche Bank upgrading the rating to Buy. Analysts’ consensus target hovers just above the current price, and the company’s balance sheet remains solid, featuring ample cash and a debt load that, while sizable, is covered by cash reserves. The combination of a modest upside potential, strong cash position, and improving earnings outlook supports a cautiously optimistic stance, while regulatory exposure in Medicaid and Medicare continues to be a key watchpoint.